About Annogen
Annogen is a company based in Amsterdam (Netherlands) founded in 2019. Annogen offers products and services including SuRE™ Platform and AIM™ Platform. Annogen operates in a competitive market with competitors including Biomodal, Aligned Bio, Singular Bio, YouScript and Nooma Bio, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$14.68 K (USD), Grant
Mar 01, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Annogen
Annogen offers a comprehensive portfolio of products and services, including SuRE™ Platform and AIM™ Platform.
Identifies and optimizes bespoke promoters for tailored gene expression.
Analyzes expression characteristics for over 100,000 transgene sites.
Funding Insights of Annogen
Investors in Annogen
Annogen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Annogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Annogen
Investment portfolio details for Annogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Annogen
Detailed financials for Annogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Annogen Comparisons
Peer comparison for Annogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Annogen
Annogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomodal, Aligned Bio, Singular Bio, YouScript and Nooma Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of DNA sequencing tools and technology for research and diagnostics
|
|
| Locked | Locked | Locked |
Nanowire-based sensors and alignment technologies are provided for molecular detection.
|
|
| Locked | Locked | Locked |
Tools for single molecule detection are developed by Singular Bio.
|
|
| Locked | Locked | Locked |
Clinical decision support software for drug interactions is developed.
|
|
| Locked | Locked | Locked |
Dual-nanopore technology is developed for genome-wide structural and epigenetic variations.
|
|
| Locked | Locked | Locked |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
Detailed competitors of Annogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Annogen
Complete news archive for Annogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Annogen
Annogen was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Annogen is headquartered in Amsterdam, Netherlands.
Annogen was founded in 2019 in Amsterdam, Netherlands, within the biotechnology sector. A platform is developed for screening genetic variations, utilizing SuRE technology to examine the entire genome for non-coding variants. Regulatory DNA elements and mutations influencing traits and diseases in humans, plants, and animals are identified. Plasmid libraries containing DNA elements are constructed, enabling quantitative mapping of promoter and enhancer activities across the human genome.
Annogen's top competitors include Biomodal, Aligned Bio and Singular Bio.
Annogen offers SuRE™ Platform and AIM™ Platform.
Annogen has 1 investor. Key investors include European Union.